Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
Abstract
An ibuprofen containing hydroalcoholic gel of pH 3.5 to 6.0 for topically treating inflammation or pain comprising an effective amount of ibuprofen; 40 to 60% alcohol, e.g. ethanol or isopropyl alcohol; 0-20% of a non-volatile solvent, e.g. propylene glycol; 2.0 to 5.0% gelling agents, e.g. 2.5% hydroxypropyl cellulose or 4.0% polyacrylic acid polymer; sufficient base, e.g. triethanolamine, to adjust the pH to between 3.5 and 6.0; and water; methods for delivering ibuprofen through the skin to treat inflammation or pain using the hydroalcoholic gel; and use of substantially pure S-ibuprofen to topically treat such inflammation or pain.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. An ibuprofen hydroalcoholic gel composition consisting essentially of by weight of the total weight of the composition: about 1 to 15% substantially pure S-ibuprofen; 0 to 20% of propylene glycol; about 40 to 60% alcohol; about 2.0 to 5.0% of a gelling agent selected from the group consisting of hydroxy propyl cellulose and polyacylic acid polymens sufficient triethanolamine to adjust the pH to a range of from 3.5 to 6.0 which is about 0.25 to 2%; and water q.s. to 100%.
2. An ibuprofen hydroalcoholic gel composition consisting essentially of by weight of the total weight of the composition: about 1 to 15% of substantially pure S-ibuprofen; about 5% propylene glycol; about 40 to 60 % alcohol; about 2.5% of hydroxypropyl cellulose or about 4% of polyacrylic acid polymer; a sufficient amount of triethanolamine to adjust the pH to a range of from 4.7 to 5.7 which is about 0.25 to 2%; and water q.s. to 100%.
3. A method for delivering the drug ibuprofen through the skin in order to treat inflammation or pain beneath the skin which comprises the steps of: incorporating an anti-inflammatory or analgesic effective amount of substantially pure S-ibuprofen into a hydroalcoholic gel; adjusting the pH of the gel to between 3.5 and 6.0; and topically administering said ibuprofen-containing gel to the skin of a patient, wherein the ibuprofen-hydroalcoholic gel administered has the following formulation in percent by weight of the total weight of the gel: about 1 to 15% of substantially pure S-ibuprofen; about 0 to 20% of a non-volatile solvent; about 40 to 60% an alcohol selected from the group consisting of ethanol and isopropyl alcohol; about 2.0 to 5.0% a gelling agent selected from the group consisting of hydroxypropyl cellulose and polyacrylic acid polymer; sufficient triethanolamine to adjust pH to 3.5 to 6, which is about 0.25 to 2% and water q.s. to 100%.
4. A method for delivering the drug ibuprofen through the skin in order to treat inflammation or pain beneath the skin which comprises the steps of: incorporating an anti-inflammatory or analgesic effective amount of substantially pure S-ibuprofen into a hydroalcoholic gel; adjusting the pH of the gel to between 3.5 and 6.0; and topically administering said ibuprofen-containing gel to the skin of a patient, wherein the ibuprofen-hydroalcoholic gel administered has the following formulation in percent by weight of the total weight of the gel: about 1 to 15% of substantially pure S-ibuprofen; about 0 to 20% of a non-volatile solvent; about 40 to 60% of ethanol or isopropyl alcohol; about 2.0 to 5.0% of hydroxypropyl cellulose or polyacrylic acid polymer and sufficient triethanolamine to adjust pH to 3.5 to 6; and water q.s. to 100%.
5. An ibuprofen hydroalcoholic gel composition consisting essentially of by weight of the total weight of the composition: about 1 to 15% of substantially pure S-ibuprofen; about 5% propylene glycol; about 40 to 60% alcohol; about 2.5% of hydroxypropyl cellulose or about 4% of polyacrylic acid polymer; a sufficient amount of triethanolamine to adjust the pH to a range of from 4.7 to 5.7; and water q.s. to 100%.Join the waitlist — get patent alerts
Track US5093133A — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.